Martina van de Neut Selected Research

7- (4- (3- (1H- inden- 3- yl)propyl)piperazin- 1- yl)- 1,3- benzoxazol- 2(3H)- one

1/2010

WS-50030 [7-{4-[3-(1H-inden-3-yl)propyl]piperazin-1-yl}-1,3-benzoxazol-2(3H)-one]: a novel dopamine D2 receptor partial agonist/serotonin reuptake inhibitor with preclinical antipsychotic-like and antidepressant-like activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martina van de Neut Research Topics

Disease

1	Bipolar Disorder (Manic Depressive Psychosis) 01/2010
1	Catalepsy 01/2010
1	Major Depressive Disorder (Major Depressive Disorders) 01/2010
1	Schizophrenia (Dementia Praecox) 01/2010
1	Treatment-Resistant Depressive Disorder 01/2010

Drug/Important Bio-Agent (IBA)

1	7- (4- (3- (1H- inden- 3- yl)propyl)piperazin- 1- yl)- 1,3- benzoxazol- 2(3H)- oneIBA 01/2010
1	Aripiprazole (Abilify)FDA Link 01/2010
1	Antidepressive Agents (Antidepressants)IBA 01/2010
1	Apomorphine FDA Link 01/2010
1	Serotonin (5 Hydroxytryptamine)IBA 01/2010
1	Antipsychotic Agents (Antipsychotics)IBA 01/2010
1	Oxidopamine (6 Hydroxydopamine)IBA 01/2010